These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


284 related items for PubMed ID: 29881283

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.
    Hihara K, Iyoda M, Tachibana S, Iseri K, Saito T, Yamamoto Y, Suzuki T, Wada Y, Matsumoto K, Shibata T.
    PLoS One; 2016; 11(6):e0158154. PubMed ID: 27355365
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Establishment and application of an immunoassay for the simultaneous detection of IgG and its subtype IgG4 autoantibodies against M-type phospholipase A2 receptor.
    Li T, Wu Q, Yang X, Zhang Y, Zhou X, Sheng H, Wang Y, Zhang Q, Liu X, Qin Y, Huang B, Wang L, He Q, Hu Z.
    Clin Biochem; 2021 Oct; 96():49-55. PubMed ID: 34252448
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy.
    Tampoia M, Migliucci F, Villani C, Abbracciavento L, Rossini M, Fumarulo R, Gesualdo L, Montinaro V.
    J Nephrol; 2018 Dec; 31(6):899-905. PubMed ID: 30187382
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Segarra-Medrano A, Jatem-Escalante E, Quiles-Pérez MT, Salcedo MT, Arbós-Via MA, Ostos H, Valtierra N, Carnicer-Cáceres C, Agraz-Pamplona I.
    Nefrologia; 2014 May 21; 34(3):353-9. PubMed ID: 24798555
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical Significance of IgG4 Level in Predicting the Activity and Outcome of Phospholipase A2 Receptor-associated Membranous Nephropathy].
    DU YY, Jiang X, Wang WR, Tang XL, Sun Y.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug 21; 44(4):579-584. PubMed ID: 36065689
    [Abstract] [Full Text] [Related]

  • 17. Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody.
    Cui HY, Li C, Li H, Wen YB, Duan L, Li Y, Yan XW, Hu YT, Chen LM, Li XM.
    Dis Markers; 2021 Aug 21; 2021():9965343. PubMed ID: 34497677
    [Abstract] [Full Text] [Related]

  • 18. [The relationship between anti-phospholipase A2 receptor antibody and idiopathic membranous nephropathy].
    Lin W, Li H, Li X, Qin Y, Su Y, Yu Y, Guan Y, Duan L, Li Y, Wen Y, Li X.
    Zhonghua Nei Ke Za Zhi; 2015 Sep 21; 54(9):783-8. PubMed ID: 26674797
    [Abstract] [Full Text] [Related]

  • 19. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
    L'Imperio V, Pieruzzi F, Sinico RA, Nebuloni M, Granata A, Smith A, Radice A, Pagni F.
    J Nephrol; 2018 Aug 21; 31(4):543-550. PubMed ID: 29626294
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.